Data which are available are based upon insulin levels which are observed during the euglycemic clamp procedure—the so-called “metabolic clearance rate” of insulin (MCR) is decreased in obesity, IGT, and type 2 diabetes. The gene discussed is INS; the disease is obesity disorder.